American CryoStem Corporation develops, markets, and licenses patented adipose tissue-based cellular technologies and related proprietary services. It focuses on clinical processing, commercial bio-banking, and application development for adipose tissue and autologous adipose-derived regenerative cells. The company's products include CELLECT validated collection, transportation, and storage system, which is a clinical solution for physicians to collect and deliver tissue samples; ATGRAFT adipose tissue storage service, a clinical fat storage solution that enables physicians to provide their patients with various tissue/cell storage options; and ATCELL adipose derived stem cells. It also offers ACSelerat cell culture media products for growing human stromal cells. In addition, the company, through its ACS Laboratories division, manufactures and sells patented and patent pending cellular, cell culture, processing, and testing products to professional, institutional, and commercial clients; and provides professional services.